Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.
S. Labidi-Galy, M. Rodrigues, J. L. Sandoval, J. Kurtz +16 more
2022Annals of Oncology66 citations Open access
Semantic Scholar

